title: Regulatory serine residues mediate phosphorylation-dependent and phosphorylation-independent activation of interferon regulatory factor 7.
abstract: Interferon regulatory factor (IRF)7 is a key transcription factor required for establishment of antiviral resistance. In response to infection, IRF7 is activated by phosphorylation through the action of the non-canonical IkappaB kinases, IkappaB kinase-epsilon and TANK-binding kinase 1. Activation leads to nuclear retention, DNA binding, and derepression of transactivation ability. Clusters of serine residues located in the carboxyl-terminal regulatory domain of IRF7 are putative targets of virus-activated kinases. However, the exact sites of phosphorylation have not yet been established. Here, we report a comprehensive structure-activity examination of potential IRF7 phosphorylation sites through analysis of mutant proteins in which specific serine residues were altered to alanine or aspartate. Phosphorylation patterns of these mutants were analyzed by two-dimensional gel electrophoresis, and their transcriptional activity was monitored by reporter assays. Essential phosphorylation events were mapped to amino acids 437-438 and a redundant set of sites at either amino acids 429-431 or 441. IRF7 recovered from infected cells was heterogeneously phosphorylated at these sites, and greater phosphorylation correlated with increased transactivation. Interestingly, a distinct serine cluster conserved in the related protein IRF3 was also essential for IRF7 activation and distal phosphorylation. However, the essential role of this motif did not appear to be fulfilled by phosphorylation. Rather, these serine residues and an adjacent leucine were required for phosphorylation at distal sites and may determine a conformational element required for function.
authors.affiliation: Unité de Virologie et Immunologie Cellulaire, Institut Pasteur, 75724 Paris, France.
authors.forename: Alexandre
authors.initials: A
authors.lastname: Caillaud
authors.forename: Ara G
authors.initials: AG
authors.lastname: Hovanessian
authors.forename: David E
authors.initials: DE
authors.lastname: Levy
authors.forename: Isabelle J
authors.initials: IJ
authors.lastname: Marié
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D019556:COS Cells; D002460:Cell Line; D002461:Cell Line, Transformed; D002522:Chlorocebus aethiops; D004268:DNA-Binding Proteins / Q000378:metabolism*; D006801:Humans; D050839:Interferon Regulatory Factor-7; D051379:Mice; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D010766:Phosphorylation; D012694:Serine / Q000235:genetics / Q000378:metabolism / Q000502:physiology*
chemical_list: D004268:DNA-Binding Proteins; C494234:IRF7 protein, human; D050839:Interferon Regulatory Factor-7; C494235:Irf7 protein, mouse; D012694:Serine
references.citation: Methods. 1998 Jul;15(3):167-74
references.pmid: 9735302
references.citation: Nature. 1993 Dec 9;366(6455):583-5
references.pmid: 7504785
references.citation: FEBS Lett. 1998 Dec 11;441(1):106-10
references.pmid: 9877175
references.citation: Int Immunol. 1999 Aug;11(8):1357-62
references.pmid: 10421793
references.citation: EMBO J. 1999 Dec 1;18(23):6694-704
references.pmid: 10581243
references.citation: Mol Cell. 2000 Mar;5(3):513-22
references.pmid: 10882136
references.citation: J Biol Chem. 2000 Nov 3;275(44):34320-7
references.pmid: 10893229
references.citation: Mol Cell Biol. 2000 Dec;20(23):8803-14
references.pmid: 11073981
references.citation: J Biol Chem. 2003 Mar 14;278(11):9441-7
references.pmid: 12524442
references.citation: J Biol Chem. 2003 May 2;278(18):15495-504
references.pmid: 12604599
references.citation: Nat Immunol. 2003 May;4(5):491-6
references.pmid: 12692549
references.citation: Science. 2003 May 16;300(5622):1148-51
references.pmid: 12702806
references.citation: J Biol Chem. 2003 Oct 10;278(41):40213-23
references.pmid: 12832416
references.citation: Nat Struct Biol. 2003 Nov;10(11):922-7
references.pmid: 14555995
references.citation: Nat Struct Biol. 2003 Nov;10(11):913-21
references.pmid: 14555996
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):233-8
references.pmid: 14679297
references.citation: J Biol Chem. 2004 Mar 12;279(11):9698-702
references.pmid: 14703513
references.citation: J Exp Med. 2004 Jun 21;199(12):1641-50
references.pmid: 15210742
references.citation: J Exp Med. 2004 Jun 21;199(12):1651-8
references.pmid: 15210743
references.citation: Nat Immunol. 2004 Jul;5(7):699-701
references.pmid: 15224097
references.citation: J Virol. 2004 Oct;78(19):10636-49
references.pmid: 15367631
references.citation: Nat Immunol. 2004 Oct;5(10):1061-8
references.pmid: 15361868
references.citation: Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15416-21
references.pmid: 15492225
references.citation: Nucleic Acids Res. 1985 Feb 11;13(3):805-23
references.pmid: 2987811
references.citation: Science. 1993 Sep 24;261(5129):1736-9
references.pmid: 8378775
references.citation: EMBO J. 1998 Nov 16;17(22):6660-9
references.pmid: 9822609